Acadia Pharmaceuticals (ACAD) Change in Inventory (2016 - 2026)

Acadia Pharmaceuticals' Change in Inventory history runs 11 years deep, the most recent figure standing at -$78000.0 for Q1 2026.

• In Q1 2026, Change in Inventory fell 100.75% year-over-year to -$78000.0; the TTM figure through Mar 2026 stood at $7.7 million (down 82.32% YoY), while the FY2025 annual figure was $18.2 million, down 63.28% from the prior year.
• Change in Inventory for Q1 2026 stood at -$78000.0, down from $4.9 million in the prior quarter.
• The five-year high for Change in Inventory was $27.1 million in Q2 2024, with the low at -$1.2 million in Q3 2025.
• The 5-year median for Change in Inventory is $3.0 million (2023), against an average of $5.5 million.
• The sharpest annual moves came in 2022 and 2023: Change in Inventory tumbled 269.31% in 2022, then surged 4960.32% in 2023.
• Acadia Pharmaceuticals' Change in Inventory stood at -$310000.0 in 2022, then soared by 4960.32% to $15.1 million in 2023, then sank by 70.64% to $4.4 million in 2024, then grew by 10.58% to $4.9 million in 2025, then slumped by 101.59% to -$78000.0 in 2026.
• Business Quant data shows ACAD's Change in Inventory at -$78000.0 in Q1 2026, $4.9 million in Q4 2025, and -$1.2 million in Q3 2025.